Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance. (Q44108202)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 July 2013

Language	Label	Description	Also known as
English	Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance.	scientific article published on 3 July 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Ana Ruiz-Garcia

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

W Byon

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

M K Smith

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

P Chan

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

M A Tortorici

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

S Riley

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

H Dai

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

J Dong

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

K Sweeney

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

C Cronenberger

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

3 July 2013

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

CPT: pharmacometrics & systems pharmacology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

e51

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Handling data below the limit of quantification in mixed effect models

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Impact of censoring data below an arbitrary quantification limit on structural model misspecification

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Impact of omission or replacement of data below the limit of quantification on parameter estimates in a two-compartment model

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored data

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Ways to fit a PK model with some data below the quantification limit

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis.

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Automated covariate model building within NONMEM.

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Assessment of actual significance levels for covariate effects in NONMEM.

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Diagnosing model diagnostics

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Variance components testing in the longitudinal mixed effects model

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Bootstrap Methods: Another Look at the Jackknife

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Model-based drug development

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008.

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Guidelines for the quality control of population pharmacokinetic-pharmacodynamic analyses: an industry perspective

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients.

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Pharmacometrics as a discipline is entering the "industrialization" phase: standards, automation, knowledge sharing, and training are critical for future success.

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

21 January 2018

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

31 March 2020

Essential pharmacokinetic information for drug dosage decisions: a concise visual presentation in the drug label

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

31 March 2020

Premarketing observational studies of population pharmacokinetics of new drugs

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

31 March 2020

Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

31 March 2020

Model appropriateness and population pharmacokinetic modeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/23836283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fundamentals of population pharmacokinetic modelling: modelling and software.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23836283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fundamentals of population pharmacokinetic modelling: validation methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/23836283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binary partition tree analysis based on region evolution and its application to tree simplification.

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2013.26

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/PSP.2013.26

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23836283%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44108202&oldid=2143307131"